These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25332447)

  • 21. Reply: Skin biopsies in the differential diagnosis of parkinsonism: are we ready for simplified protocols?
    Zange L; Noack C; Hahn K; Lipp A; Stenzel W
    Brain; 2016 Jan; 139(Pt 1):e6. PubMed ID: 26351269
    [No Abstract]   [Full Text] [Related]  

  • 22. Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease.
    Woulfe JM; Gray MT; Munoz G
    Neurology; 2015 Sep; 85(9):834. PubMed ID: 26554094
    [No Abstract]   [Full Text] [Related]  

  • 23. Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson disease.
    Ruffmann C; Parkkinen L
    Neurology; 2015 Sep; 85(9):834. PubMed ID: 26324865
    [No Abstract]   [Full Text] [Related]  

  • 24. Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse's central nervous system by two novel monoclonal antibodies.
    Vivacqua G; Casini A; Vaccaro R; Fornai F; Yu S; D'Este L
    J Chem Neuroanat; 2011 Mar; 41(2):97-110. PubMed ID: 21172422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain.
    Totterdell S; Meredith GE
    Neuroscience; 2005; 135(3):907-13. PubMed ID: 16112475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A colonic biomarker of Parkinson's disease?
    Olanow CW
    Mov Disord; 2012 May; 27(6):674-6. PubMed ID: 22649001
    [No Abstract]   [Full Text] [Related]  

  • 27. Is α-synuclein rising to the surface as a diagnostic biomarker for Parkinson disease?
    Cheshire WP; Pfeiffer RF
    Neurology; 2013 Oct; 81(18):1568-9. PubMed ID: 24089391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson disease: Peripheral α-synuclein deposits - prodromal markers for Parkinson disease?
    Wood H
    Nat Rev Neurol; 2016 May; 12(5):249. PubMed ID: 27080519
    [No Abstract]   [Full Text] [Related]  

  • 29. Skin nerve phosphorylated α-synuclein deposits in idiopathic REM sleep behavior disorder.
    Antelmi E; Donadio V; Incensi A; Plazzi G; Liguori R
    Neurology; 2017 May; 88(22):2128-2131. PubMed ID: 28468843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.
    Schneider SA; Boettner M; Alexoudi A; Zorenkov D; Deuschl G; Wedel T
    Eur J Neurol; 2016 Feb; 23(2):247-61. PubMed ID: 26100920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease.
    Miki Y; Tomiyama M; Ueno T; Haga R; Nishijima H; Suzuki C; Mori F; Kaimori M; Baba M; Wakabayashi K
    Neurosci Lett; 2010 Jan; 469(3):357-9. PubMed ID: 20026177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reply to: Gray et al.
    Visanji NP; Marras C; Liu LW; Hazrati LN; Lang AE
    Mov Disord; 2014 Aug; 29(9):1225-6. PubMed ID: 24925804
    [No Abstract]   [Full Text] [Related]  

  • 34. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
    Shannon KM; Keshavarzian A; Dodiya HB; Jakate S; Kordower JH
    Mov Disord; 2012 May; 27(6):716-9. PubMed ID: 22550057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease.
    Lee JM; Derkinderen P; Kordower JH; Freeman R; Munoz DG; Kremer T; Zago W; Hutten SJ; Adler CH; Serrano GE; Beach TG
    J Neuropathol Exp Neurol; 2017 Jan; 76(1):2-15. PubMed ID: 28069931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease.
    Visanji NP; Mollenhauer B; Beach TG; Adler CH; Coffey CS; Kopil CM; Dave KD; Foroud T; Chahine L; Jennings D;
    Biomark Med; 2017 Apr; 11(4):359-368. PubMed ID: 28353371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
    Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities.
    Lööv C; Scherzer CR; Hyman BT; Breakefield XO; Ingelsson M
    Cell Mol Neurobiol; 2016 Apr; 36(3):437-48. PubMed ID: 26993503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
    Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
    Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure.
    Shishido T; Ikemura M; Obi T; Yamazaki K; Terada T; Sugiura A; Saito Y; Murayama S; Mizoguchi K
    Neurology; 2010 Feb; 74(7):608-10. PubMed ID: 20157164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.